153 related articles for article (PubMed ID: 2167709)
1. Vaccination against SIV infection and disease.
Gardner MB
AIDS Res Hum Retroviruses; 1990 Jul; 6(7):835-46. PubMed ID: 2167709
[No Abstract] [Full Text] [Related]
2. Inactivated whole SIV vaccine in macaques: evaluation of protective efficacy against challenge with cell-free virus or infected cells.
Johnson PR; Montefiori DC; Goldstein S; Hamm TE; Zhou J; Kitov S; Haigwood NL; Misher L; London WT; Gerin JL
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1501-5. PubMed ID: 1466990
[No Abstract] [Full Text] [Related]
3. SIV and FIV vaccine studies at UC Davis: 1991 update.
Gardner M; Yamamoto J; Marthas M; Miller C; Jennings M; Rosenthal A; Luciw P; Planelles V; Yilma T; Giavedoni L
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1495-8. PubMed ID: 1334682
[No Abstract] [Full Text] [Related]
4. SIV infected rhesus macaques: an AIDS model for immunoprevention and immunotherapy.
Gardner MB
Adv Exp Med Biol; 1989; 251():279-93. PubMed ID: 2558527
[TBL] [Abstract][Full Text] [Related]
5. A formalin-inactivated whole SIV vaccine confers protection in macaques.
Murphey-Corb M; Martin LN; Davison-Fairburn B; Montelaro RC; Miller M; West M; Ohkawa S; Baskin GB; Zhang JY; Putney SD
Science; 1989 Dec; 246(4935):1293-7. PubMed ID: 2555923
[TBL] [Abstract][Full Text] [Related]
6. A formalin-fixed whole SIV vaccine induces protective responses that are cross-protective and durable.
Murphey-Corb M; Ohkawa S; Davison-Fairburn B; Martin LN; Baskin GB; Langlois AJ; McIntee M; Narayan O; Gardner MB
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1475-8. PubMed ID: 1466986
[No Abstract] [Full Text] [Related]
7. Vaccine studies with the 32H reisolate of SIVmac251: an overview.
Cranage M; Stott J; Mills K; Ashworth T; Taffs F; Farrar G; Chan L; Dennis M; Putkonen P; Biberfeld G
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1479-81. PubMed ID: 1466987
[No Abstract] [Full Text] [Related]
8. Use of simian immunodeficiency virus for evaluation of AIDS vaccine strategies.
Daniel MD; Desrosiers RC
AIDS; 1989; 3 Suppl 1():S131-3. PubMed ID: 2558686
[No Abstract] [Full Text] [Related]
9. Vaccination against HIV and SIV.
Leclerc C
Curr Opin Immunol; 1989-1990 Feb; 2(3):428-32. PubMed ID: 2483885
[No Abstract] [Full Text] [Related]
10. Immune responses to SIVmne envelope glycoproteins protect macaques from homologous SIV infection.
Hu SL; Travis BM; Stallard V; Abrams K; Misher L; Moran P; Zarling JM; Langlois AJ; Kuller L; Morton WR
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1489-94. PubMed ID: 1466988
[No Abstract] [Full Text] [Related]
11. Postexposure immunotherapy of simian immunodeficiency virus (SIV) infected rhesus with an SIV immunogen.
Gardner MB; Jennings M; Carlson JR; Lerche N; McGraw T; Luciw P; Marx P; Pedersen N
J Med Primatol; 1989; 18(3-4):321-8. PubMed ID: 2547966
[TBL] [Abstract][Full Text] [Related]
12. A formalin inactivated whole SIV vaccine and a glycoprotein-enriched subunit vaccine confers protection against experimental challenge with pathogenic live SIV in rhesus monkeys.
Murphey-Corb M; Martin LN; Davison-Fairburn B; Montelaro RC; Miller M; West M; Ohkawa S; Baskin GB; Zhang JY; Putney S
Dev Biol Stand; 1990; 72():273-85. PubMed ID: 2282987
[No Abstract] [Full Text] [Related]
13. Summary of the SIV Working Group.
Schultz AM
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1439-40. PubMed ID: 1466977
[No Abstract] [Full Text] [Related]
14. Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines.
Heeney JL; de Vries P; Dubbes R; Koornstra W; Niphuis H; ten Haaft P; Boes J; Dings ME; Morein B; Osterhaus AD
J Med Primatol; 1992; 21(2-3):126-30. PubMed ID: 1433263
[TBL] [Abstract][Full Text] [Related]
15. Progress in vaccine development against SIV and HIV.
Bolognesi DP
J Acquir Immune Defic Syndr (1988); 1990; 3(4):390-4. PubMed ID: 1690288
[No Abstract] [Full Text] [Related]
16. Modern vaccines. Human immunodeficiency virus and AIDS: challenges and progress.
Schild GC; Minor PD
Lancet; 1990 May; 335(8697):1081-4. PubMed ID: 1970381
[No Abstract] [Full Text] [Related]
17. Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone, but not with BK28-derived recombinant env and gag proteins.
Mills KH; Page M; Chan WL; Kitchin P; Stott EJ; Taffs F; Jones W; Rose J; Ling C; Silvera P
J Med Primatol; 1992; 21(2-3):50-8. PubMed ID: 1433267
[TBL] [Abstract][Full Text] [Related]
18. Animal models for HIV infection and AIDS: memorandum from a WHO meeting.
Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118
[TBL] [Abstract][Full Text] [Related]
19. Vaccine protection of rhesus macaques against simian immunodeficiency virus infection.
Carlson JR; McGraw TP; Keddie E; Yee JL; Rosenthal A; Langlois AJ; Dickover R; Donovan R; Luciw PA; Jennings MB
AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1239-46. PubMed ID: 2078406
[TBL] [Abstract][Full Text] [Related]
20. [Immunization against HIV. Problems in developing a vaccine].
Uhl D
Med Monatsschr Pharm; 1988 Nov; 11(11):376-8. PubMed ID: 3059163
[No Abstract] [Full Text] [Related]
[Next] [New Search]